EPISODE · Mar 23, 2026 · 24 MIN
CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson
from Hematologic Oncology Update
Dr Paul G Richardson from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses how CELMoDs function, available data with these agents and their possible future role in the treatment of multiple myeloma.CME information and select publications here.
Embed this episode
NOW PLAYING
CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson
0:00
24:29
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Hematologic Oncology Update?
This episode is 24 minutes long.
When was this Hematologic Oncology Update episode published?
This episode was published on March 23, 2026.
Can I download this Hematologic Oncology Update episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!